NYSE · Healthcare
METTLER TOLEDO INTERNATIONAL INC/ (MTD)
As-reported financials and recent SEC filings for METTLER TOLEDO INTERNATIONAL INC/, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$4.03B
Net income
$869.2M
Net margin
21.6%
Diluted EPS
$42.05
ROE
-3677.4%
P/E (TTM)
26.6×
Market cap
$22.86B
Debt / equity
-88.4×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $4.03B | $3.87B | $3.79B | $3.92B | $3.72B |
| Gross profit | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Net income | $869.2M | $863.1M | $788.8M | $872.5M | $769.0M |
| Diluted EPS | $42.05 | $40.48 | $35.90 | $38.41 | $32.78 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
SD2026-05-29
View on EDGAR →42026-05-14
View on EDGAR →42026-05-14
View on EDGAR →42026-05-14
View on EDGAR →42026-05-14
View on EDGAR →42026-05-14
View on EDGAR →42026-05-14
View on EDGAR →8-K2026-05-13
View on EDGAR →Go deeper on MTD
Search METTLER TOLEDO INTERNATIONAL INC/’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.